These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27777594)

  • 1. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU).
    Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ
    Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of controlled exposure to house dust mite in the environmental exposure unit (EEU).
    Hossenbaccus L; Linton S; Thiele J; Steacy L; Walker T; Malone C; Ellis AK
    Allergy Asthma Clin Immunol; 2021 Mar; 17(1):34. PubMed ID: 33771217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU).
    Ellis AK; Steacy LM; Hobsbawn B; Conway CE; Walker TJ
    Allergy Asthma Clin Immunol; 2015; 11(1):5. PubMed ID: 25653682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental exposure unit simulates natural seasonal birch pollen exposures while maximizing change in allergic symptoms.
    Ellis AK; DeVeaux M; Steacy L; Ramesh D; Suprun M; Langdon S; Wang CQ; Adams D; Thiele J; Walker T; Perlee LT; O'Brien MP
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):488-495.e5. PubMed ID: 34186172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients.
    Bergmann KC; Krause L; Hiller J; Becker S; Kugler S; Tapparo M; Pfaar O; Zuberbier T; Kramer MF; Guethoff S; Graessel A
    World Allergy Organ J; 2021 Jan; 14(1):100494. PubMed ID: 33376575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season.
    Gherasim A; Dietsch F; Beck M; Domis N; de Blay F
    World Allergy Organ J; 2023 Jul; 16(7):100801. PubMed ID: 37520615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.
    Ellis AK; Soliman M; Steacy L; Boulay MÈ; Boulet LP; Keith PK; Vliagoftis H; Waserman S; Neighbour H
    Allergy Asthma Clin Immunol; 2015; 11(1):16. PubMed ID: 25945101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge.
    Olivieri B; Gil AJ; Stoenchev K; Durham SR; Scadding G
    Clin Transl Allergy; 2024 May; 14(5):e12360. PubMed ID: 38779783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit.
    Ellis AK; Steacy LM; Joshi A; Bhowmik S; Raut A
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):310-7. PubMed ID: 27613466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit.
    North ML; Jones MJ; MacIsaac JL; Morin AM; Steacy LM; Gregor A; Kobor MS; Ellis AK
    Allergy; 2018 Jan; 73(1):196-205. PubMed ID: 28755526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA
    Boelke G; Berger U; Bergmann KC; Bindslev-Jensen C; Bousquet J; Gildemeister J; Jutel M; Pfaar O; Sehlinger T; Zuberbier T
    Clin Transl Allergy; 2017; 7():33. PubMed ID: 28932387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical and clinical validation of the Allergen BioCube
    Angjeli E; Gomes P; Lane KJ; Stein L; Abelson MB
    Immun Inflamm Dis; 2017 Mar; 5(1):78-84. PubMed ID: 28250927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas-An EAACI Task Force Report.
    Pfaar O; Karatzas K; Bastl K; Berger U; Buters J; Darsow U; Demoly P; Durham SR; Galán C; Gehrig R; Gerth van Wijk R; Jacobsen L; Katsifarakis N; Klimek L; Saarto A; Sofiev M; Thibaudon M; Werchan B; Bergmann KC
    Allergy; 2020 May; 75(5):1099-1106. PubMed ID: 31721236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo-controlled crossover park study.
    Kenney P; Hilberg O; Laursen AC; Peel RG; Sigsgaard T
    J Allergy Clin Immunol; 2015 Dec; 136(6):1566-1572.e5. PubMed ID: 26141263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of nasal allergen challenge results: Further validation of the allergic rhinitis clinical investigator collaborative protocols.
    Soliman M; Steacy LM; Thiele J; Adams DE; Neighbour HL; Ellis AK
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):607-613. PubMed ID: 29432965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial.
    Unger-Manhart N; Morokutti-Kurz M; Zieglmayer PU; Lemell P; Savli M; Zieglmayer R; Prieschl-Grassauer E
    Int J Gen Med; 2024; 17():419-428. PubMed ID: 38333020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.
    North ML; Walker TJ; Steacy LM; Hobsbawn BG; Allan RJ; Hackman F; Sun X; Day AG; Ellis AK
    Allergy Asthma Clin Immunol; 2014; 10(1):33. PubMed ID: 25024716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score.
    Tenn MW; Steacy LM; Ng CC; Ellis AK
    Allergy Asthma Clin Immunol; 2018; 14():5. PubMed ID: 29371864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
    JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.